Topic
Stat
Recent coverage of Stat from across the web.
-
STAT+: BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDA -
STAT+: China competition, ‘destruction’ at FDA give agency chance to restructure, Rick Pazdur says -
STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug -
STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer -
STAT+: The woman behind the world’s biggest longevity competition -
STAT+: As Ebola outbreak in Central Africa grows, the U.S. turns itself into a fortress -
STAT+: Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show -
STAT+: Congress slashed Medicaid funding to providers. The Trump administration wants to cut even further
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow